Well discuss the National Plan to address alzheimers disease and focus on newly funded research. The drugs will be used preventively on Healthy People genetically predeposed to develop the disease. Well start our discussion in a moment. First this background. What i noticed maybe four or five years ago was my difficulty in writing about complex topics. I just couldnt hold all of them at the same time in my mind, so it became much more difficult. And frustrating to try to write about those. I think david is a doctor, teacher, and avid blogger. These days hes writing about a topic that hits close to home. What im trying to do is take my family and my community with me into this journey so that i dont get isolated as much. The Alzheimers Association said there are 5 million alzheimers sufferers in the u. S. Its the sixth leading cause of death in the United States. In 2011 president obama signed into law the national alzheimers project act. Its incredibly important work and its only going
United-states
Arizona
Alexandria
Al-iskandariyah
Egypt
China
Minnesota
Sandy-hook
Washington
District-of-columbia
Denver
Colorado
A new drug to treat cognitive decline and help fight the cause of brain deterioration in those with Alzheimer’s is now poised for Food and Drug Administration approval.It’s called Lecanemab, and it works by attacking sticky plaque buildup in the brain, sort of how cholesterol-fighting drugs work.But, Dr. Pierre Tariot with Barrow Neurological Institute said the drug is not for
Pierre-tariot
Barrow-neurological-institute
Drug-administration